The golden autumn days come with gleaming sunshine and cool breezes. On October 25, 2024, UnionClin officially relocated its headquarters to the Science Gate of Zhangjiang Science City in Pudong, which means that UnionClin has taken another solid step forward on the path of continuous pursuit of excellence and efficient development.

Since its establishment in 2017, UnionClin has always upheld the mission of "accelerating clinical studies for new drugs and seeking new life for thousands of patients" and has won the trust of numerous clients with high-quality service, abundant clinical resources, and innovative digital intelligence tools. This relocation is an important decision made based on UnionClin's strategic development plan and business expansion needs. It not only expresses our determination to continuously enhance our service scale but also reflects our full confidence in the future of the industry.

As a Chinese idiom that the oriole moves to the tall tree, while the swallow enters the high building, the new headquarters is located in Zhangjiang Science City in the central part of Pudong New Area, Shanghai, within the new landmark Zhangjiang Science Gate. The biopharmaceutical industry is one of the six most distinctive and advantageous core industries in the Pudong New Area. As a representative of national high-tech industrial parks, Zhangjiang holds a pivotal position. With strong policy support for "industry-medical integration," a rich scientific research atmosphere, and a concentration of numerous high-quality pharmaceutical companies, the environment is elegant, and transportation is convenient. While being closer to clients, it creates a more comfortable and efficient working environment for employees, providing broader space and superior conditions for the company's future development.

After moving into the new location, relying on strong resource advantages, we will continue to deepen cooperation and exchanges with all parties, actively explore business fields and innovative service models, and enhance our core competitiveness. Upholding our original intention, we are committed to becoming a better clinical CRO for new drugs in the fields of oncology, infection/communicable diseases, autoimmunity, metabolism/cardiovascular system, and neurology, providing sponsors with more comprehensive and efficient clinical research solutions, and making greater contributions to accelerating the transformation of medical and technological achievements and promoting the high-quality development of the entire biopharmaceutical innovation chain in Pudong.

We warmly welcome industry colleagues to visit for guidance, engage in exchanges and cooperation, and jointly compose a new chapter of development!

Address

New Address of UnionClin Shanghai Headquarters:

10th Floor, No. 1, Lane 188, Yuren Road, Pudong New Area, Shanghai (Science Gate T2)